Literature DB >> 27617207

Disseminated Nocardia farcinica in an immunocompetent patient.

H Boamah1, P Puranam1, R M Sandre2.   

Abstract

Nocardia farcinica is a gram-positive, partially acid-fast, methenamine silver-positive aerobic actinomycete that is infrequently associated with nocardiosis. The relative frequency of Nocardia farcinica isolates in nocardiosis is unknown but thought to be under diagnosis. It is increasingly been recognized in immunocompetent patients. We report a case of disseminated Nocardia farcinica causing brain abscess in 55 year old immunocompetent man who was successfully treated with long term antibiotics. The present report illustrates that early detection and treatment of disseminated Nocardia farcinica can lead to a good outcome.

Entities:  

Keywords:  Disseminated brain abscess; Immunocompetent; Nocardia farcinica

Year:  2016        PMID: 27617207      PMCID: PMC5007420          DOI: 10.1016/j.idcr.2016.08.003

Source DB:  PubMed          Journal:  IDCases        ISSN: 2214-2509


Introduction

Disseminated Nocardiosis is an opportunistic infection that is usually seen in immunocompromised hosts. Nocardia farcinica is a rare cause of nocardiosis but is increasingly been recognized as a potentially lethal infection in immunocompetent patients (1–3). This report describes a patient with disseminated infection due to Nocardia farcinica.

Case presentation

A 55-year-old man presented to the emergency room with a three week history of throbbing and persistent right occipital headaches radiating to his frontal region. The headaches were not associated with any aura, photophobia, nausea or vomiting. The patient also had recurrent complaints of fevers and nocturnal diaphoresis. After presenting to a walk-in clinic and diagnosed with a presumptive viral infection. No antibiotic medication was prescribed. His past medical history included smoking and gastro-esophageal reflux disease. There was no history of any prior headaches, tuberculosis or exposure, positive tubercullin skin tests, syphilis, gonorrhea, chlamydia, human immunodeficiency virus (HIV), malignancies, hepatitis, recent surgeries, workplace exposure or recent travel. His physical examination showed a healthy appearing man, hemodynamically stable with a high grade fever of 39.5 °C. His neurological exam, cardiac exam, respiratory exam and abdominal exam were all normal. Investigations revealed white blood cell count of 13.1 × 109/L (with 87% polymorphonuclear cells, 4% monocytes, and 9% lymphocytes), hemoglobin 136 g/L, platelet count 367 × 109/L and a normal serum chemistry panel including transaminases. His absolute CD4 count was 449 × 10 (6)/L and his HIV serology was non-reactive. Chest radiograph however revealed wedge-shaped nodular opacity measuring 3.1 × 3.25 cm in the left upper lobe adjacent to the pleura (Fig. 1). A lumbar puncture showed 3065 × 106/L of white blood cells (normal 0–5 × 106/L), 1.1 mmol/L of glucose (normal 2.2–3.9 mmol/L) and 1.90 g/L of total protein (normal 0.12–0.6 mmol/L). Preliminary CSF cultures did not grow any organism. The patient was then started on ceftriaxone, vancomycin and ampicillin.
Fig. 1

Chest radiograph showing a wedge-shaped nodular opacity measuring 3.1 × 3.25 cm in the left upper lobe adjacent to the pleura.

A computed tomography (CT) of the chest and abdomen with intravenous contrast revealed a large spiculated 2.8 × 4.5 × 3.7 cm subpleural mass in the lateral aspect of the left upper lung lobe and a smaller spiculated and eccentrically cavitary 1.4 cm nodule in the posterior and subpleural aspect of the left lower lobe (Fig. 2). There was no hilar or mediastinal lymphadenopathy. Initial computed tomography of the head was normal but a follow up Multisequence Multiplanar Unenhanced Magnetic Resonance Image (MRI) of the head with gadolinium showed a T2 hypointense lesion involving the left head of the caudate nucleus with perifocal edema suspicious for a fungal abscess (Fig. 3).
Fig. 2

Chest CT scan showing subpleural mass in the lateral aspect of the left upper lung lobe and a smaller spiculated and eccentrically cavitary 1.4 cm nodule in the posterior and subpleural aspect of the left lower lobe.

Fig. 3

MRI of the head with gadolinium shows a T2 hypointense lesion involving the left head of the caudate nucleus with perifocal edema suspicious for a fungal abscess.

The patient’s headaches and fever continued to persist so a computed tomographic guided biopsy of the large spiculated subpleural mass of the left upper lobe was performed as well as repeat lumbar puncture. Both the lung tissue biopsy and the repeated CSF fluid cultures grew beaded branching gram positive bacill. Molecular studies using the Multi-Locus sequence analysis (MLSA) identified the species as Nocarida farcinica. Further susceptibility testing showed the organism was susceptible to amoxicillin/clavulanic acid, imipenem, linezolid, moxifloxacin and trimethoprim/sulfamethoxazole (TMP-SMX) but resistant to ceftriaxone (Fig. 4).
Fig. 4

CSF culture showing beaded branching gram positive bacilli.

Ceftriaxone, vancomycin and ampicillin were discontinued and the patient was treated initially with imipenem for six weeks followed by TMP-SMX for one year.

Discussion

We present a rare case of disseminated Nocardia farcinica originating from the lungs and causing a brain abscess in an immunocompetent patient. Nocardiosis is an opportunistic infection causing localized or disseminated disease and caused by the soil-dwelling, weakly gram-positive aerobic actinomycete Nocardia. It predominately presents as an acute, subacute or chronic pulmonary disease in immunocompromised hosts that can disseminate to any organ, forming abscesses [1]. Nocardia asteroides and Nocardia brasiliensis are the two species most frequently involved in human disease [2]. Nocardia farcinica is a gram-positive, partially acid-fast, methenamine silver-positive aerobic actinomycete infrequently associated with nocardiosis [3]. However it can cause clinically aggressive and potentially lethal disseminated infections in immunocompromised patients. It is also known to be resistant to multiple antimicrobial agents. It is rarely reported as a cause of nocardiosis in immunocompetent hosts [4]. The relative frequency of Nocardia farcinica isolates in nocardiosis is unknown but thought to be underdiagnosed and is increasingly been recognized in immunocompetent patients [2]. The diagnosis of Nocardia farcinica requires the isolation and identification of the organism from tissue, culture specimen or both [3]. Since nocardia is a slow growing organism it may be difficult to detect the organism on hematoxylin and eosin (H & E) stain and acid-fast stain [5]. Usually gram and methenamine silver (GMS) stain is positive. Cultures of nocardia species can take up to five days or more to grow and PCR identification of the16S ribosomal RNA of the organisms is rapid but not always available in all laboratories [6]. Nocardia Farcinica has specific drug susceptibility patterns. Nocardia Farcinica is resistant to most beta-lactam antibiotics, aminoglycosides but susceptible to amikacin [7], [8]. Nocardiosis is treated usually with combinations of TMP-SMX, imipenem-cilastatin, moxifloxacin, amikacin, linezolid, minocycline or ciprofloxacin for a duration of six to twelve months depending on central nervous system involvement. The most commonly used antibiotic reported is TMP-SMX [9], [10]. A literature search revealed very few reported cases of disseminated Nocardia farcinica in immunocompetent host, their treatment with antibiotics and outcomes (Table 1). Other cases of Nocardia farcinica brain abscess in immunocompetent patients have been reported in the literature [10], [13], [14], [15], [16]. Table 2 shows their treatments and outcomes.
Table 1

Reported cases of disseminated Nocardia farcinica in immunocompetent host, treatments and outcomes.

Cases of Disseminated Nocardia farcinica in immunocompetent hostTreatmentsOutcomes
Budzik et al. [1]Monotherapy with TMP-SMXThe patient dead after 11 days of admission
Singh et al. [11]Co-trimoxazole and amikacinResponded to treatment and survived
Tachezy et al. [12]Imipenem/Cilastatin, amikacin and TMP-SMX for six weeks followed by TMX-SMX for twelve monthsThe patient’s neurological status improved. Repeated MRI six month later showed that the brain abscess had become smaller or completely disappeared.
Table 2

Nocardia farcinica brain abscess in immunocompetent host, treatments and outcomes.

Cases of Nocardia farcinicaBrain abscess in immunocompetent hostTreatmentsOutcomes
Malincarne et al. [10]Amikacin, meropenem, TMP-SMX and cranitomy with drainage of the abscessClinical and radiographic improvement after 35 days of treatment
Kim et al. [13]Imipenem initially then switched to meropenem, ciprofloxacin, TMP-SMX and craniotomy with stereotactic aspiration of the abscessImprovement in the patient’s symptoms. Repeated CT scan of the head on three month follow-up showed resolution of the brain abscess
Izawa et al. [14]2 case reportsCase 1: Pazufloxacin, ciprofloxacin and craniotomy and burr hole drainageCase 2: Pazufloxacin, meropenem, amikacin, minocycline, linezolid, TMP-SMX and craniotomy and burr hole drainageCase 1: Good response to treatmentCase 2: Brain abscess alleviated but the patient’s general condition worsened leading to death
Kandasamy et al. [15]Co-trimoxazole and moxifloxacin and craniotomy and abscess drainageExcellent response to treatment
Fellows et al. [16]Moxifloxacin and surgeryResponded to treatment
After a year of treatment, the patient had complete resolution of his symptoms of headache, fever and night sweats. A repeated MRI of his head showed almost complete resolution of the left caudate nucleus abscess and a repeat CT scan of his chest showed an interval improvement in the size of his left upper lobe mass.

Conclusion

Nocardia farcinica is infrequently associated with nocardiosis especially in immunocompetent patients. It is however associated with very aggressive and lethal disseminated infections in immunocompromised patients. Early detection and treatment can lead to a successful patient outcome.

Consent section

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Conflict of interest

Authors have no conflict of interest to report.
  16 in total

1.  Primary brain abscess with Nocardia farcinica in an immunocompetent patient.

Authors:  Lisa Malincarne; Massimo Marroni; Claudio Farina; Guido Camanni; Marina Valente; Barbara Belfiori; Stefano Fiorucci; Piero Floridi; Angela Cardaccia; Giuliano Stagni
Journal:  Clin Neurol Neurosurg       Date:  2002-05       Impact factor: 1.876

Review 2.  Nocardiosis.

Authors:  P I Lerner
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

Review 3.  Nocardia farcinica brain abscess: epidemiology, pathophysiology, and literature review.

Authors:  V Anil Kumar; Deepthi Augustine; Dilip Panikar; Aswathy Nandakumar; Kavitha R Dinesh; Shamsul Karim; Rosamma Philip
Journal:  Surg Infect (Larchmt)       Date:  2014-08-15       Impact factor: 2.150

4.  [Two cases of Nocardia farcinica brain abscess].

Authors:  Daisuke Izawa; Kazushige Sakano; Hirotaka Okumura; Toshikazu Kuwata; Naoki Tsuji
Journal:  No Shinkei Geka       Date:  2011-12

5.  Disseminated nocardiosis in an immunocompetent child.

Authors:  N P Singh; Renu Goyal; Vikas Manchanda; Piyush Gupta
Journal:  Ann Trop Paediatr       Date:  2003-03

Review 6.  Nocardial brain abscess: treatment strategies and factors influencing outcome.

Authors:  A N Mamelak; W G Obana; J F Flaherty; M L Rosenblum
Journal:  Neurosurgery       Date:  1994-10       Impact factor: 4.654

7.  Nocardial infections in the United States, 1972-1974.

Authors:  B L Beaman; J Burnside; B Edwards; W Causey
Journal:  J Infect Dis       Date:  1976-09       Impact factor: 5.226

8.  Primary Nocardia farcinica brain abscess with secondary meningitis and ventriculitis in an immunocompetent patient, successfully treated with moxifloxacin.

Authors:  J Kandasamy; H J Iqbal; R P D Cooke; P R Eldridge
Journal:  Acta Neurochir (Wien)       Date:  2008-04-15       Impact factor: 2.216

Review 9.  Abscess of adrenal gland caused by disseminated subacute Nocardia farcinica pneumonia. A case report and mini-review of the literature.

Authors:  Michael Tachezy; Philipp Simon; Corina Ilchmann; Yogesh K Vashist; Jakob R Izbicki; Karim A Gawad
Journal:  BMC Infect Dis       Date:  2009-12-02       Impact factor: 3.090

10.  Nocardia brain abscess in an immunocompetent patient.

Authors:  Suyoung Kim; Kang Lock Lee; Dong Min Lee; Ji Hun Jeong; Song Mi Moon; Yiel-Hae Seo; Chan Jong Yoo; Dongki Yang; Yong Kyun Cho; Yoon Soo Park
Journal:  Infect Chemother       Date:  2014-03-21
View more
  6 in total

1.  Disseminated nocardiosis caused by Nocardia farcinica in a patient with colon cancer: A case report and literature review.

Authors:  Eung Kyum Lee; Jin Kim; Dong-Hyuk Park; Chang Kyu Lee; Sun Bean Kim; Jang Wook Sohn; Young Kyung Yoon
Journal:  Medicine (Baltimore)       Date:  2021-07-23       Impact factor: 1.817

2.  Disseminated Nocardiosis Associated with Treatment with Infliximab in a Patient with Ulcerative Colitis.

Authors:  Orlando Garner; Ana Ramirez-Berlioz; Alfredo Iardino; Satish Mocherla; Kalpana Bhairavarasu
Journal:  Am J Case Rep       Date:  2017-12-21

Review 3.  A clinical case report of brain abscess caused by Nocardia brasiliensis in a non-immunocompromised patient and a relevant literature review.

Authors:  Jian-Wei Zhu; Hui Zhou; Wei-Qiang Jia; Jian You; Ru-Xiang Xu
Journal:  BMC Infect Dis       Date:  2020-05-07       Impact factor: 3.090

4.  Nocardia farcinica Brain Abscess in an Immunocompetent Host With Pulmonary Alveolar Proteinosis: A Case Report and Review of the Literature.

Authors:  Sarah E Grond; Alyssa Schaller; Alexandra Kalinowski; Kimberly A Tyler; Pinky Jha
Journal:  Cureus       Date:  2020-11-15

5.  Pulmonary and cutaneous infection caused by Nocardia farcinica in a patient with nephrotic syndrome: A case report.

Authors:  Ning Zhu; Yuan Zhu; Yi Wang; Shaoshao Dong
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

6.  An Unusual Presentation From a Sporadic Partially Acid-Fast Aerobic Actinomycete Resistant to Common Antibiotics.

Authors:  Sreedhar Adapa; Srikanth Naramala; Vijay Gayam; Rajan Kapoor; Mina Raju; Pallav Patel; Venu Madhav Konala
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.